BrightAccountsProduction v1.0.0 v1.0.0 2023-07-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts The principal activity of the company in the year under review was that of the provision of sports and recreation education and other sports activities. 28 March 2025 0 0 12652769 2024-06-30 12652769 2023-06-30 12652769 2022-06-30 12652769 2023-07-01 2024-06-30 12652769 2022-07-01 2023-06-30 12652769 uk-bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 12652769 uk-curr:PoundSterling 2023-07-01 2024-06-30 12652769 uk-bus:SmallCompaniesRegimeForAccounts 2023-07-01 2024-06-30 12652769 uk-bus:FullAccounts 2023-07-01 2024-06-30 12652769 uk-bus:Director1 2023-07-01 2024-06-30 12652769 uk-bus:Director2 2023-07-01 2024-06-30 12652769 uk-bus:Director3 2023-07-01 2024-06-30 12652769 uk-bus:RegisteredOffice 2023-07-01 2024-06-30 12652769 uk-bus:Agent1 2023-07-01 2024-06-30 12652769 uk-core:ShareCapital 2024-06-30 12652769 uk-core:ShareCapital 2023-06-30 12652769 uk-core:RetainedEarningsAccumulatedLosses 2024-06-30 12652769 uk-core:RetainedEarningsAccumulatedLosses 2023-06-30 12652769 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2024-06-30 12652769 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2023-06-30 12652769 uk-bus:FRS102 2023-07-01 2024-06-30 12652769 uk-core:WithinOneYear 2024-06-30 12652769 uk-core:WithinOneYear 2023-06-30 12652769 2023-07-01 2024-06-30 12652769 uk-bus:AuditExempt-NoAccountantsReport 2023-07-01 2024-06-30 xbrli:pure iso4217:GBP xbrli:shares
 
 
 
Pernix Health Ltd
 
UNAUDITED FINANCIAL STATEMENTS
 
for the financial year ended 30 June 2024
PERNIX HEALTH LTD
DIRECTORS AND OTHER INFORMATION

 
DIRECTORS Andrew Michael Penniceard
Dominic Charles Tripp
Susannah Claire Hudson
 
 
COMPANY REGISTRATION NUMBER 12652769
 
 
REGISTERED OFFICE Berkeley House
Amery Street
Alton
Hampshire
GU34 1HN
 
 
ACCOUNTANTS Styles and Associates Ltd
Berkeley House
Amery Street
Alton
Hampshire
GU34 1HN



PERNIX HEALTH LTD
Company Registration Number: 12652769
BALANCE SHEET
as at 30 June 2024

2024 2023
Notes £ £
 
CURRENT ASSETS
Cash at bank and in hand 14,931 2,971
CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR 5 (27,834) (9,689)
───────── ─────────
NET CURRENT LIABILITIES (12,903) (6,718)
───────── ─────────
TOTAL ASSETS LESS CURRENT LIABILITIES (12,903) (6,718)
═════════ ═════════
 
CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings (12,904) (6,719)
───────── ─────────
SHAREHOLDERS' DEFICIT (12,903) (6,718)
═════════ ═════════
 
The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).
           
The company has taken advantage of the exemption under section 444 not to file the Profit and Loss Account and Directors' Report.
           
For the financial year ended 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
           
The directors confirm that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.
           
The directors acknowledge their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
           
Approved by the Board and authorised for issue on 28 March 2025 and signed on its behalf by
           
           
________________________________          
Susannah Claire Hudson          
DIRECTOR          
           



PERNIX HEALTH LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 30 JUNE 2024

   
1. GENERAL INFORMATION
 
Pernix Health Ltd is a company limited by shares is a company limited by shares is a private company, registered in England and Wales. This company's registered number and registered office address can be found on the information page.

The presentation currency of the financial statements is the pound.

Accounts are rounded to the nearest pound.

The accounts represent the company as individual entity.
         
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
 
STATEMENT OF COMPLIANCE
The financial statements of the company for the financial year ended 30 June 2024 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.
 
BASIS OF PREPARATION
The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.
 
TURNOVER
Turnover represents net invoiced sales of goods and services, excluding value added tax.
 
TRADE AND OTHER CREDITORS
Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.
 
TAXATION AND DEFERRED TAXATION
Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Balance Sheet date.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more tax in the future, or a right to pay less tax in the future. Timing differences are temporary differences between the company's taxable profits and its results as stated in the financial statements. Deferred tax is measured on an undiscounted basis at the tax rates that are anticipated to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the Balance Sheet date.
 
FOREIGN CURRENCIES
Monetary assets and liabilities denominated in foreign currencies are translated at the rates of exchange ruling at the Balance Sheet date. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated at the rates of exchange ruling at the date of the transaction. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined. The resulting exchange differences are dealt with in the Profit and Loss Account.
 
ORDINARY SHARE CAPITAL
The ordinary share capital of the company is presented as equity.
   
3. SIGNIFICANT ACCOUNTING JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY
 
In preparing the financial statements in accordance with FRS 102, management is required to make judgements, estimates, and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income, and expenses. Actual results may differ from these estimates.

Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period or in the period of the revision and future periods if the revision affects both current and future periods.
       
4. EMPLOYEES
 
The average monthly number of employees, including directors, during the financial year was 0, (2023 - 0).
       
5. CREDITORS 2024 2023
AMOUNTS FALLING DUE WITHIN ONE YEAR £ £
 
Directors' current accounts 27,194 9,199
Other creditors 240 240
Accruals 400 250
  ───────── ─────────
  27,834 9,689
  ═════════ ═════════
   
6. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES
 
At the year end, the company owed the directors £27,194 (2023: £9,199).
       
7. SHARE CAPITAL 2024 2023
  £ £
 
ALLOTTED, CALLED UP AND FULLY PAID Ordinary - Number of Shares: 1 - Value of Units: £1.00 each 1 1
  ═════════ ═════════
   
8. CONTROLLING INTEREST
 
The ultimate controlling party is A Penniceard.